PDF(Pubmed)
Abstract：
BACKGROUND: Human Papillomavirus (HPV) vaccination rates are still below the target due to vaccine refusal or delay, lack of knowledge, and logistical challenges. Understanding these barriers is crucial for developing strategies to improve HPV vaccination rates.
METHODS: This cross-sectional study used a questionnaire to investigate social and behavioral factors influencing decision making about the HPV vaccine. The survey was conducted from 11 April to 29 May 2022 and involved 10,000 Italian citizens aged ≥ 18 years. The sample was stratified based on region of residence, gender, and age group.
RESULTS: 3160 participants were surveyed about themselves, while 1266 respondents were surveyed about their children\'s vaccine uptake. Among females aged ≥ 26 years, the national average HPV vaccine uptake was 21.7%, with variations across different regions. In the 18-25 age group, females had a vaccine uptake (80.8%) twice as much as males (38.1%), while vaccine uptake among male and female children aged 9-11 was similar.
CONCLUSIONS: The OBVIOUS study in Italy reveals factors influencing low HPV vaccine uptake, suggesting targeted approaches, tailored information campaigns, heightened awareness of eligibility, promoting early vaccination, addressing low-risk perception among males, addressing safety concerns, and enhancing perceived accessibility to improve vaccine uptake and mitigate health risks.
METHODS: This cross-sectional study used a questionnaire to investigate social and behavioral factors influencing decision making about the HPV vaccine. The survey was conducted from 11 April to 29 May 2022 and involved 10,000 Italian citizens aged ≥ 18 years. The sample was stratified based on region of residence, gender, and age group.
RESULTS: 3160 participants were surveyed about themselves, while 1266 respondents were surveyed about their children\'s vaccine uptake. Among females aged ≥ 26 years, the national average HPV vaccine uptake was 21.7%, with variations across different regions. In the 18-25 age group, females had a vaccine uptake (80.8%) twice as much as males (38.1%), while vaccine uptake among male and female children aged 9-11 was similar.
CONCLUSIONS: The OBVIOUS study in Italy reveals factors influencing low HPV vaccine uptake, suggesting targeted approaches, tailored information campaigns, heightened awareness of eligibility, promoting early vaccination, addressing low-risk perception among males, addressing safety concerns, and enhancing perceived accessibility to improve vaccine uptake and mitigate health risks.
摘要：
背景：由于疫苗拒绝或延迟，人乳头瘤病毒（HPV）疫苗接种率仍低于目标，缺乏知识,和后勤挑战。了解这些障碍对于制定提高HPV疫苗接种率的策略至关重要。
方法：这项横断面研究使用问卷调查影响HPV疫苗决策的社会和行为因素。该调查于2022年4月11日至5月29日进行，涉及10,000名年龄≥18岁的意大利公民。样本是根据居住地区分层的，性别,和年龄组。
结果：对3160名参与者进行了自我调查，而1266名受访者接受了关于他们孩子疫苗接种情况的调查。在≥26岁的女性中，全国HPV疫苗平均摄入量为21.7%，不同地区的差异。在18-25岁年龄段，女性的疫苗摄入量（80.8％）是男性（38.1％）的两倍，而9-11岁男女儿童的疫苗摄入量相似。
结论：意大利的OVIOUS研究揭示了影响低HPV疫苗摄取的因素，建议有针对性的方法，量身定制的信息活动，提高资格意识，促进早期疫苗接种，解决男性的低风险感知，解决安全问题，并增强感知的可及性，以提高疫苗的吸收并减轻健康风险。
方法：这项横断面研究使用问卷调查影响HPV疫苗决策的社会和行为因素。该调查于2022年4月11日至5月29日进行，涉及10,000名年龄≥18岁的意大利公民。样本是根据居住地区分层的，性别,和年龄组。
结果：对3160名参与者进行了自我调查，而1266名受访者接受了关于他们孩子疫苗接种情况的调查。在≥26岁的女性中，全国HPV疫苗平均摄入量为21.7%，不同地区的差异。在18-25岁年龄段，女性的疫苗摄入量（80.8％）是男性（38.1％）的两倍，而9-11岁男女儿童的疫苗摄入量相似。
结论：意大利的OVIOUS研究揭示了影响低HPV疫苗摄取的因素，建议有针对性的方法，量身定制的信息活动，提高资格意识，促进早期疫苗接种，解决男性的低风险感知，解决安全问题，并增强感知的可及性，以提高疫苗的吸收并减轻健康风险。
